MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 48 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $119 | -23.7% | 331,846 | 0.0% | 0.33% | -12.6% |
Q1 2023 | $156 | -6.0% | 331,846 | 0.0% | 0.37% | -19.7% |
Q4 2022 | $166 | -99.9% | 331,846 | 0.0% | 0.47% | +2.0% |
Q3 2022 | $211,000 | -19.5% | 331,846 | 0.0% | 0.46% | +6.0% |
Q2 2022 | $262,000 | -67.4% | 331,846 | -66.8% | 0.43% | -43.8% |
Q1 2022 | $804,000 | -58.1% | 1,000,000 | -47.4% | 0.77% | -39.5% |
Q4 2021 | $1,919,000 | -13.2% | 1,900,000 | +11.8% | 1.27% | +7.0% |
Q3 2021 | $2,210,000 | +90.2% | 1,700,000 | +13.3% | 1.18% | +70.4% |
Q2 2021 | $1,162,000 | – | 1,500,000 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alliance Wealth Management Group | 400,826 | $465,000 | 0.23% |
Yellowstone Partners, LLC | 143,914 | $167,000 | 0.09% |
IFP Advisors, Inc | 251,172 | $291,000 | 0.01% |
HYMAN CHARLES D | 79,800 | $93,000 | 0.01% |
Virtu Financial LLC | 106,146 | $123,000 | 0.01% |
Raymond James Financial Services Advisors, Inc. | 659,890 | $765,000 | 0.01% |
Tower Research Capital LLC (TRC) | 21,181 | $25,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 189,000 | $219,000 | 0.00% |
BlackRock Inc. | 2,530,508 | $2,935,000 | 0.00% |
Bank of New York Mellon Corp | 175,325 | $203,000 | 0.00% |